Over the past decade, cancer treatment has gone from a one-size-fits-all approach to a targeted and personal approach known widely as Precision Medicine.
  Among the leaders at TGen pushing the boundaries of this new frontier is Dr. Sunil Sharma, Deputy Director of TGen Clinical Sciences, Professor, and Division Director in the Applied Cancer Research and Drug Discovery division.
  Dr. Sharma is a well-known cancer investigator, responsible for helping develop some of the world’s most advanced anti-cancer agents. 
  In episode 22 of TGen Talks, Dr. Sharma discusses his work in drug development and patient clinical trials in concert with City of Hope in California, and TGen’s clinical partnership with the HonorHealth Research Institute. Whether in the clinic, or at the bench, his work helps bring precision medicine solutions to patients
in need.

Ver todos los episodios